Literature DB >> 36138196

Pressure pain threshold map of thoracolumbar paraspinal muscles after lengthening contractions in young male asymptomatic volunteers.

Kohei Hanada1, Hiroki Ota1,2, Kazue Mizumura3, Toru Taguchi4,5.   

Abstract

This study aimed to characterise topographic distribution of pressure pain thresholds (PPTs) of thoracolumbar paraspinal muscles and its change after lengthening contractions (LCs) of the back muscles. Using young male asymptomatic participants in Experiment 1, we systematically examined the distribution of PPTs bilaterally in the range of Th1-L5 at measurement points 2 and 4 cm from the midline. PPTs were found to be higher in the lumbar segments of the paraspinal muscles than in the thoracic segments, and in muscles closer to the vertebrae (2 vs. 4 cm from the midline). The PPTs did not differ between the left and right sides in each segment. In Experiment 2, LC was applied by asking a part of participants recruited in Experiment 1 to fall their trunk from a starting position (parallel to the floor) to 40° flexed position, and then made it back as quickly as possible to the starting position. This cycle was repeated until participants could not keep contractions (30 times/set, 25.4 ± 10.6 sets). PPTs of the LC group decreased prominently in the lower thoracic and lumbar segments, and the decrease was more evident 24 h after LC compared to that 48 h after. In contrast, PPTs in the control group without LC remained unchanged. These results provided broad topographic images of PPTs in the thoracolumbar paraspinal muscles of young male participants with and without LC, and the obtained PPT maps could be a useful guide for better treatment of exercise-induced myofascial pain in the lower back.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36138196     DOI: 10.1038/s41598-022-20071-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  58 in total

Review 1.  Delayed onset muscle soreness : treatment strategies and performance factors.

Authors:  Karoline Cheung; Patria Hume; Linda Maxwell
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  Acute inflammation: the underlying mechanism in delayed onset muscle soreness?

Authors:  L L Smith
Journal:  Med Sci Sports Exerc       Date:  1991-05       Impact factor: 5.411

3.  Muscle fibre size and type distribution in thoracic and lumbar regions of erector spinae in healthy subjects without low back pain: normal values and sex differences.

Authors:  A F Mannion; G A Dumas; R G Cooper; F J Espinosa; M W Faris; J M Stevenson
Journal:  J Anat       Date:  1997-05       Impact factor: 2.610

Review 4.  Delayed onset muscle soreness: Involvement of neurotrophic factors.

Authors:  Kazue Mizumura; Toru Taguchi
Journal:  J Physiol Sci       Date:  2016-01       Impact factor: 2.781

Review 5.  Nociception from skeletal muscle in relation to clinical muscle pain.

Authors:  S Mense
Journal:  Pain       Date:  1993-09       Impact factor: 6.961

6.  Fiber type composition of the vastus lateralis muscle of young men and women.

Authors:  R S Staron; F C Hagerman; R S Hikida; T F Murray; D P Hostler; M T Crill; K E Ragg; K Toma
Journal:  J Histochem Cytochem       Date:  2000-05       Impact factor: 2.479

7.  Effect of indomethacin on the development of eccentric exercise-induced localized sensitive region in the fascia of the rabbit.

Authors:  Kazunori Itoh; Kenji Kawakita
Journal:  Jpn J Physiol       Date:  2002-04

Review 8.  Low back pain: diagnosis, treatment, and prognosis.

Authors:  A Indahl
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641

Review 9.  Low back pain.

Authors:  Nebojsa Nick Knezevic; Kenneth D Candido; Johan W S Vlaeyen; Jan Van Zundert; Steven P Cohen
Journal:  Lancet       Date:  2021-06-08       Impact factor: 79.321

10.  Prevalence and characteristics of chronic musculoskeletal pain in Japan.

Authors:  Masaya Nakamura; Yuji Nishiwaki; Takahiro Ushida; Yoshiaki Toyama
Journal:  J Orthop Sci       Date:  2011-06-16       Impact factor: 1.601

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.